These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37038954)

  • 1. Prognostic value of initial [ 18 F]FDG PET/computed tomography volumetric and texture analysis-based parameters in patients with head and neck squamous cell carcinoma.
    Elahmadawy MA; Ashraf A; Moustafa H; Kotb M; Abd El-Gaid S
    Nucl Med Commun; 2023 Jul; 44(7):653-662. PubMed ID: 37038954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of pretreatment (18)F-FDG PET-CT metabolic parameters in patients with advanced extranodal NK/T cell lymphoma].
    Wu LL; Liang JH; Wang L; Xu W; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):831-836. PubMed ID: 31770850
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma.
    Gupta T; Chatterjee A; Rangarajan V; Purandare N; Arya S; Murthy V; Budrukkar A; Ghosh-Laskar S; Agarwal JP
    Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):162-170. PubMed ID: 31496204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of
    Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
    Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic value of textural indices extracted from pretherapeutic 18-F FDG-PET/CT in head and neck squamous cell carcinoma.
    Guezennec C; Robin P; Orlhac F; Bourhis D; Delcroix O; Gobel Y; Rousset J; Schick U; Salaün PY; Abgral R
    Head Neck; 2019 Feb; 41(2):495-502. PubMed ID: 30549149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of (18)F-FDG PET-CT imaging to predict epidermal growth factor receptor mutations in patients with lung squamous cell carcinoma].
    Zhao CY; Deng XY; Wang HS; Cao GP; Ding JN; Ding CY
    Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):795-800. PubMed ID: 34289575
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis.
    Jin A; Lin X; Yin X; Cui Y; Ma L
    Medicine (Baltimore); 2022 Sep; 101(39):e30798. PubMed ID: 36181127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of volumetric 4'-[methyl-
    Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y
    Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Prognostic Value of FDG PET/CT Parameters for Patients With Surgically Treated Head and Neck Cancer: A Systematic Review.
    Creff G; Devillers A; Depeursinge A; Palard-Novello X; Acosta O; Jegoux F; Castelli J
    JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):471-479. PubMed ID: 32215611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
    Hu WD; Wang HC; Wang YB; Cui LL; Chen XH
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.
    Paidpally V; Chirindel A; Chung CH; Richmon J; Koch W; Quon H; Subramaniam RM
    AJR Am J Roentgenol; 2014 Aug; 203(2):W139-45. PubMed ID: 25055289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical value of texture analysis of dual-time-point
    Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy.
    Hanamoto A; Tatsumi M; Takenaka Y; Hamasaki T; Yasui T; Nakahara S; Yamamoto Y; Seo Y; Isohashi F; Ogawa K; Hatazawa J; Inohara H
    Cancer Med; 2014 Oct; 3(5):1368-76. PubMed ID: 25045041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of FDG-PET/CT parameters for the assessment of the immune status in advanced HNSCC.
    Ohashi T; Terasawa K; Aoki M; Akazawa T; Shibata H; Kuze B; Asano T; Kato H; Miyazaki T; Matsuo M; Inoue N; Ito Y
    Auris Nasus Larynx; 2020 Aug; 47(4):658-667. PubMed ID: 32089351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
    Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.